Neurological manifestations in xeroderma pigmentosum

Area of Science:

• Neurogenetics
• Dermatology
• Neurology

Background:

• Xeroderma pigmentosum (XP) is a rare neurocutaneous disorder.
• Patients are classified into 10 groups using somatic cell hybridization.
• Group A XP presents unique challenges in understanding its neurological impact.

Purpose of the Study:

• To investigate the neurological complications in 32 patients with Group A xeroderma pigmentosum.
• To characterize the clinical and electrophysiological findings in affected individuals.
• To compare a typical Group A case with an atypical presentation.

Main Methods:

• Clinical assessment of neurological symptoms in 32 Group A XP patients.
• Electroencephalography (EEG) to evaluate brain activity.
• Cranial computed tomography (CT) scans for neuroimaging.
• Analysis of cellular repair mechanisms (post-ultraviolet colony-forming ability and host cell reactivation) in an atypical case.

Main Results:

• Prevalence of microcephaly (17/32), short stature (13/32), and mental retardation (21/32).
• Sensorineural deafness and spinocerebellar signs (nystagmus, dysarthria, tremor, ataxia) were common in patients over 7 years old.
• EEG showed abnormal slow, low-voltage activity; CT scans revealed ventricular dilatation, cerebral and cerebellar atrophy, and cranial bone thickening.
• An atypical case exhibited milder skin and neurological symptoms, correlating with better cellular DNA repair capacity.

Conclusions:

• Group A xeroderma pigmentosum is associated with significant neurological morbidity, including developmental delays and progressive neurodegeneration.
• Age is a critical factor in the manifestation of certain neurological complications, particularly sensorineural deafness and spinocerebellar signs.
• Cellular repair efficiency may influence the clinical severity of Group A XP, suggesting potential therapeutic targets.